Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Navidea Biopharmaceuticals Inc (NY: NAVB )

2.050 USD UNCHANGED
Streaming Delayed Price Updated: 8:00 PM EST, Mar 8, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Navidea Biopharmaceuticals Inc

< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
Navidea Biopharmaceuticals to Present at the H.C. Wainwright Global Life Sciences Virtual Conference
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, announces that... 
From Business Wire News Releases
Navidea Biopharmaceuticals Announces $5 Million Private Placement with Existing Investor
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, is pleased to... 
From Business Wire News Releases
The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Market News SRDX CCXI
From Benzinga
4 Penny Stocks You Might’ve Missed If You’re Ignoring Biotech Right Now
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Navidea Biopharmaceuticals Announces Submission of Formal Type B Meeting Request with FDA and Launch of NAV3-32 Phase 2B Trial in Rheumatoid Arthritis
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, is pleased to... 
From Business Wire News Releases
Navidea Biopharmaceuticals to Present at the 2021 ICR Conference On January 14, 2021
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced... 
From Business Wire News Releases
Navidea Biopharmaceuticals Strengthens Board of Directors with the Appointment of Malcolm Witter
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced... 
From Business Wire News Releases
48 Stocks Moving In Tuesday's Mid-Day Session
Gainers Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) shares climbed 42.7% to $1.8409 as the company disclosed that both the ... 
Tags MGEN TSLA CBAT
From Benzinga
41 Stocks Moving in Tuesday's Pre-Market Session
Gainers Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) shares rose 62.8% to $2.10 in pre-market trading as the company disclosed ... 
Tags BTBT TREE CAN
From Benzinga
35 Stocks Moving in Monday's Pre-Market Session
Gainers Alterity Therapeutics Limited (NASDAQ: ATHE) shares rose 169% to $3.09 in pre-market trading as the company announced ... 
Tags Movers MHLD PLTR
From Benzinga
65 Biggest Movers From Friday
Gainers Urovant Sciences Ltd. (NASDAQ: UROV) shares jumped 93.5% to close at $16.02 on Friday after the company late Thursday ... 
Tags LYL IPHA News
From Benzinga
54 Stocks Moving In Friday's Mid-Day Session
Gainers Urovant Sciences Ltd. (NASDAQ: UROV) shares climbed 94% to $16.06 after the company late Thursday announced Sumitovant ... 
Tags CBAT Small Cap IMAC
From Benzinga
The Daily Biotech Pulse: Urovant In M&A Deal, Sanofi's Binary Event, Conference Presentations
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags CBAY HALO KPTI
From Benzinga
46 Stocks Moving in Friday's Pre-Market Session
Gainers Urovant Sciences Ltd. (NASDAQ: UROV) rose 87% to $15.48 in pre-market trading. Sumitovant Biopharma will acquire Urovant ... 
Tags Top Gainers NBY AWX
From Benzinga
13 Stocks Moving In Thursday's After-Hours Session
Gainers Cisco Systems (NASDAQ: CSCO)shares are trading higher after the company reported better-than-expected Q1 EPS and ... 
Tags OSS Movers ECOR
From Benzinga
Navidea Biopharmaceuticals Reports Third Quarter and Year-to-Date 2020 Financial Results
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced... 
From Business Wire News Releases
Navidea Biopharmaceuticals Announces Positive Results Encompassing Additional Patients From Its Ongoing Phase 2B Study in Rheumatoid Arthritis
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, is pleased to... 
From Business Wire News Releases
The Daily Biotech Pulse: AstraZeneca's Cancer Drug Flunks COVID-19 Studies, Five Prime On a Roll, Morphosys, Xencor, Incyte Strike Cancer Deal
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags BIOC IBB SLGL
From Benzinga
Earnings Scheduled For November 12, 2020
Companies Reporting Before The Bell • Redhill Biopharma (NASDAQ:RDHL) is projected to report quarterly loss at $0.16 ... 
Tags VNRX THMO DDS
From Benzinga
The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions
Biotech stocks turned around with the broader market in the week ended Nov. 6, as investors warmed to the idea of a split Congress and a ... 
Tags RMED INFI CMPI
From Benzinga
Navidea Biopharmaceuticals to Host Third Quarter 2020 Earnings Conference Call and Corporate Update
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced it... 
From Business Wire News Releases
Navidea Biopharmaceuticals to Present at the Virtual Investor KOL Roundtable
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced... 
From Business Wire News Releases
Navidea Biopharmaceuticals Announces Acceptance of Abstract for Presentation at the American College of Rheumatology Annual Meeting
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced... 
From Business Wire News Releases
Navidea Biopharmaceuticals to Ring Opening Bell at the New York Stock Exchange
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced... 
From Business Wire News Releases
Navidea Biopharmaceuticals to Present at H.C. Wainwright 22nd Annual Global Investment Conference
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced... 
From Business Wire News Releases
Navidea Biopharmaceuticals Wins Dismissal of Platinum Loan Litigation
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, is pleased to... 
From Business Wire News Releases
Navidea Biopharmaceuticals to Present at The LD 500 Virtual Investor Conference
Navidea Biopharmaceuticals, Inc. (NYSE American:NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced... 
From Business Wire News Releases
65 Stocks Moving In Friday's Mid-Day Session
Gainers Mesoblast Limited (NASDAQ: MESO) climbed 43.4% to $16.94 after the company said FDA's Oncologic Drugs Advisory ... 
Tags AWH DGLY SBSW
From Benzinga
The Daily Biotech Pulse: Adcom Rules In Favor Of Mesoblast, CureVac IPO, Novavax Clinches UK COVID-19 Vaccine Deal
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 13) Aerpio Pharmaceuticals Inc (NASDAQ: ARPO) Fulgent ... 
Tags THMO NAOV FMTX
From Benzinga
46 Stocks Moving in Friday's Pre-Market Session
Gainers China Automotive Systems, Inc. (NASDAQ: CAAS) shares rose 46.5% to $4.38 in pre-market trading after the company reported ... 
Tags SJ VRNA GSX
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.